Description

The global Dihydropyridine Vasodilators market size is expected to reach $ 1850 million by 2031, rising at a market growth of -2.3% CAGR during the forecast period (2025-2031).

Dihydropyridine vasodilators are a subclass of calcium channel blockers that primarily act on vascular smooth muscle to induce vasodilation by inhibiting L-type calcium channels. They are widely used in the treatment of hypertension and certain types of angina due to their potent ability to lower peripheral vascular resistance. Key drugs in this class include nifedipine, amlodipine, and felodipine, which are characterized by minimal cardiac effects compared to other calcium channel blockers.

This report studies the global Dihydropyridine Vasodilators demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Dihydropyridine Vasodilators, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2024 as the base year. This report explores demand trends and competition, as well as details the characteristics of Dihydropyridine Vasodilators that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Dihydropyridine Vasodilators total market, 2020-2031, (USD Million)
Global Dihydropyridine Vasodilators total market by region & country, CAGR, 2020-2031, (USD Million)
U.S. VS China: Dihydropyridine Vasodilators total market, key domestic companies, and share, (USD Million)
Global Dihydropyridine Vasodilators revenue by player, revenue and market share 2020-2025, (USD Million)
Global Dihydropyridine Vasodilators total market by Type, CAGR, 2020-2031, (USD Million)
Global Dihydropyridine Vasodilators total market by Application, CAGR, 2020-2031, (USD Million)
This report profiles major players in the global Dihydropyridine Vasodilators market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Huanghai Pharma, Shyndec Pharma, Beijing Hongling Pharma, Ingenus Pharmaceutical, Sine Pharma, AstraZeneca, Lifeon Pharma, Teva, Nanjing Easeheal Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Dihydropyridine Vasodilators market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2020-2031 by year with 2024 as the base year, 2025 as the estimate year, and 2026-2031 as the forecast year.

Global Dihydropyridine Vasodilators Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Dihydropyridine Vasodilators Market, Segmentation by Type
    Nifedipine
    Iradipine
    Felodipine
    Nicardipine
    Other

Global Dihydropyridine Vasodilators Market, Segmentation by Application:
    Hospital
    Retail Pharmacy
    Other

Companies Profiled:
    Bayer
    Huanghai Pharma
    Shyndec Pharma
    Beijing Hongling Pharma
    Ingenus Pharmaceutical
    Sine Pharma
    AstraZeneca
    Lifeon Pharma
    Teva
    Nanjing Easeheal Pharma
    Novartis
    Baxter International
    Hikma Pharmaceuticals
    Astellas Pharma
    Aguettant

Key Questions Answered
1. How big is the global Dihydropyridine Vasodilators market?
2. What is the demand of the global Dihydropyridine Vasodilators market?
3. What is the year over year growth of the global Dihydropyridine Vasodilators market?
4. What is the total value of the global Dihydropyridine Vasodilators market?
5. Who are the Major Players in the global Dihydropyridine Vasodilators market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Dihydropyridine Vasodilators Introduction
    1.2 World Dihydropyridine Vasodilators Market Size & Forecast (2020 & 2024 & 2031)
    1.3 World Dihydropyridine Vasodilators Total Market by Region (by Headquarter Location)
        1.3.1 World Dihydropyridine Vasodilators Market Size by Region (2020-2031), (by Headquarter Location)
        1.3.2 United States Based Company Dihydropyridine Vasodilators Revenue (2020-2031)
        1.3.3 China Based Company Dihydropyridine Vasodilators Revenue (2020-2031)
        1.3.4 Europe Based Company Dihydropyridine Vasodilators Revenue (2020-2031)
        1.3.5 Japan Based Company Dihydropyridine Vasodilators Revenue (2020-2031)
        1.3.6 South Korea Based Company Dihydropyridine Vasodilators Revenue (2020-2031)
        1.3.7 ASEAN Based Company Dihydropyridine Vasodilators Revenue (2020-2031)
        1.3.8 India Based Company Dihydropyridine Vasodilators Revenue (2020-2031)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Dihydropyridine Vasodilators Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Dihydropyridine Vasodilators Consumption Value (2020-2031)
    2.2 World Dihydropyridine Vasodilators Consumption Value by Region
        2.2.1 World Dihydropyridine Vasodilators Consumption Value by Region (2020-2025)
        2.2.2 World Dihydropyridine Vasodilators Consumption Value Forecast by Region (2026-2031)
    2.3 United States Dihydropyridine Vasodilators Consumption Value (2020-2031)
    2.4 China Dihydropyridine Vasodilators Consumption Value (2020-2031)
    2.5 Europe Dihydropyridine Vasodilators Consumption Value (2020-2031)
    2.6 Japan Dihydropyridine Vasodilators Consumption Value (2020-2031)
    2.7 South Korea Dihydropyridine Vasodilators Consumption Value (2020-2031)
    2.8 ASEAN Dihydropyridine Vasodilators Consumption Value (2020-2031)
    2.9 India Dihydropyridine Vasodilators Consumption Value (2020-2031)

3 World Dihydropyridine Vasodilators Companies Competitive Analysis
    3.1 World Dihydropyridine Vasodilators Revenue by Player (2020-2025)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Dihydropyridine Vasodilators Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Dihydropyridine Vasodilators in 2024
        3.2.3 Global Concentration Ratios (CR8) for Dihydropyridine Vasodilators in 2024
    3.3 Dihydropyridine Vasodilators Company Evaluation Quadrant
    3.4 Dihydropyridine Vasodilators Market: Overall Company Footprint Analysis
        3.4.1 Dihydropyridine Vasodilators Market: Region Footprint
        3.4.2 Dihydropyridine Vasodilators Market: Company Product Type Footprint
        3.4.3 Dihydropyridine Vasodilators Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Dihydropyridine Vasodilators Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Dihydropyridine Vasodilators Revenue Comparison (2020 & 2024 & 2031) (by Headquarter Location)
        4.1.2 United States VS China: Dihydropyridine Vasodilators Revenue Market Share Comparison (2020 & 2024 & 2031)
    4.2 United States Based Companies VS China Based Companies: Dihydropyridine Vasodilators Consumption Value Comparison
        4.2.1 United States VS China: Dihydropyridine Vasodilators Consumption Value Comparison (2020 & 2024 & 2031)
        4.2.2 United States VS China: Dihydropyridine Vasodilators Consumption Value Market Share Comparison (2020 & 2024 & 2031)
    4.3 United States Based Dihydropyridine Vasodilators Companies and Market Share, 2020-2025
        4.3.1 United States Based Dihydropyridine Vasodilators Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Dihydropyridine Vasodilators Revenue, (2020-2025)
    4.4 China Based Companies Dihydropyridine Vasodilators Revenue and Market Share, 2020-2025
        4.4.1 China Based Dihydropyridine Vasodilators Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Dihydropyridine Vasodilators Revenue, (2020-2025)
    4.5 Rest of World Based Dihydropyridine Vasodilators Companies and Market Share, 2020-2025
        4.5.1 Rest of World Based Dihydropyridine Vasodilators Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Dihydropyridine Vasodilators Revenue (2020-2025)

5 Market Analysis by Type
    5.1 World Dihydropyridine Vasodilators Market Size Overview by Type: 2020 VS 2024 VS 2031
    5.2 Segment Introduction by Type
        5.2.1 Nifedipine
        5.2.2 Iradipine
        5.2.3 Felodipine
        5.2.4 Nicardipine
        5.2.5 Other
    5.3 Market Segment by Type
        5.3.1 World Dihydropyridine Vasodilators Market Size by Type (2020-2025)
        5.3.2 World Dihydropyridine Vasodilators Market Size by Type (2026-2031)
        5.3.3 World Dihydropyridine Vasodilators Market Size Market Share by Type (2026-2031)

6 Market Analysis by Application
    6.1 World Dihydropyridine Vasodilators Market Size Overview by Application: 2020 VS 2024 VS 2031
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Retail Pharmacy
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World Dihydropyridine Vasodilators Market Size by Application (2020-2025)
        6.3.2 World Dihydropyridine Vasodilators Market Size by Application (2026-2031)
        6.3.3 World Dihydropyridine Vasodilators Market Size Market Share by Application (2020-2031)

7 Company Profiles
    7.1 Bayer
        7.1.1 Bayer Details
        7.1.2 Bayer Major Business
        7.1.3 Bayer Dihydropyridine Vasodilators Product and Services
        7.1.4 Bayer Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025)
        7.1.5 Bayer Recent Developments/Updates
        7.1.6 Bayer Competitive Strengths & Weaknesses
    7.2 Huanghai Pharma
        7.2.1 Huanghai Pharma Details
        7.2.2 Huanghai Pharma Major Business
        7.2.3 Huanghai Pharma Dihydropyridine Vasodilators Product and Services
        7.2.4 Huanghai Pharma Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025)
        7.2.5 Huanghai Pharma Recent Developments/Updates
        7.2.6 Huanghai Pharma Competitive Strengths & Weaknesses
    7.3 Shyndec Pharma
        7.3.1 Shyndec Pharma Details
        7.3.2 Shyndec Pharma Major Business
        7.3.3 Shyndec Pharma Dihydropyridine Vasodilators Product and Services
        7.3.4 Shyndec Pharma Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025)
        7.3.5 Shyndec Pharma Recent Developments/Updates
        7.3.6 Shyndec Pharma Competitive Strengths & Weaknesses
    7.4 Beijing Hongling Pharma
        7.4.1 Beijing Hongling Pharma Details
        7.4.2 Beijing Hongling Pharma Major Business
        7.4.3 Beijing Hongling Pharma Dihydropyridine Vasodilators Product and Services
        7.4.4 Beijing Hongling Pharma Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025)
        7.4.5 Beijing Hongling Pharma Recent Developments/Updates
        7.4.6 Beijing Hongling Pharma Competitive Strengths & Weaknesses
    7.5 Ingenus Pharmaceutical
        7.5.1 Ingenus Pharmaceutical Details
        7.5.2 Ingenus Pharmaceutical Major Business
        7.5.3 Ingenus Pharmaceutical Dihydropyridine Vasodilators Product and Services
        7.5.4 Ingenus Pharmaceutical Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025)
        7.5.5 Ingenus Pharmaceutical Recent Developments/Updates
        7.5.6 Ingenus Pharmaceutical Competitive Strengths & Weaknesses
    7.6 Sine Pharma
        7.6.1 Sine Pharma Details
        7.6.2 Sine Pharma Major Business
        7.6.3 Sine Pharma Dihydropyridine Vasodilators Product and Services
        7.6.4 Sine Pharma Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025)
        7.6.5 Sine Pharma Recent Developments/Updates
        7.6.6 Sine Pharma Competitive Strengths & Weaknesses
    7.7 AstraZeneca
        7.7.1 AstraZeneca Details
        7.7.2 AstraZeneca Major Business
        7.7.3 AstraZeneca Dihydropyridine Vasodilators Product and Services
        7.7.4 AstraZeneca Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025)
        7.7.5 AstraZeneca Recent Developments/Updates
        7.7.6 AstraZeneca Competitive Strengths & Weaknesses
    7.8 Lifeon Pharma
        7.8.1 Lifeon Pharma Details
        7.8.2 Lifeon Pharma Major Business
        7.8.3 Lifeon Pharma Dihydropyridine Vasodilators Product and Services
        7.8.4 Lifeon Pharma Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025)
        7.8.5 Lifeon Pharma Recent Developments/Updates
        7.8.6 Lifeon Pharma Competitive Strengths & Weaknesses
    7.9 Teva
        7.9.1 Teva Details
        7.9.2 Teva Major Business
        7.9.3 Teva Dihydropyridine Vasodilators Product and Services
        7.9.4 Teva Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025)
        7.9.5 Teva Recent Developments/Updates
        7.9.6 Teva Competitive Strengths & Weaknesses
    7.10 Nanjing Easeheal Pharma
        7.10.1 Nanjing Easeheal Pharma Details
        7.10.2 Nanjing Easeheal Pharma Major Business
        7.10.3 Nanjing Easeheal Pharma Dihydropyridine Vasodilators Product and Services
        7.10.4 Nanjing Easeheal Pharma Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025)
        7.10.5 Nanjing Easeheal Pharma Recent Developments/Updates
        7.10.6 Nanjing Easeheal Pharma Competitive Strengths & Weaknesses
    7.11 Novartis
        7.11.1 Novartis Details
        7.11.2 Novartis Major Business
        7.11.3 Novartis Dihydropyridine Vasodilators Product and Services
        7.11.4 Novartis Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025)
        7.11.5 Novartis Recent Developments/Updates
        7.11.6 Novartis Competitive Strengths & Weaknesses
    7.12 Baxter International
        7.12.1 Baxter International Details
        7.12.2 Baxter International Major Business
        7.12.3 Baxter International Dihydropyridine Vasodilators Product and Services
        7.12.4 Baxter International Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025)
        7.12.5 Baxter International Recent Developments/Updates
        7.12.6 Baxter International Competitive Strengths & Weaknesses
    7.13 Hikma Pharmaceuticals
        7.13.1 Hikma Pharmaceuticals Details
        7.13.2 Hikma Pharmaceuticals Major Business
        7.13.3 Hikma Pharmaceuticals Dihydropyridine Vasodilators Product and Services
        7.13.4 Hikma Pharmaceuticals Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025)
        7.13.5 Hikma Pharmaceuticals Recent Developments/Updates
        7.13.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
    7.14 Astellas Pharma
        7.14.1 Astellas Pharma Details
        7.14.2 Astellas Pharma Major Business
        7.14.3 Astellas Pharma Dihydropyridine Vasodilators Product and Services
        7.14.4 Astellas Pharma Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025)
        7.14.5 Astellas Pharma Recent Developments/Updates
        7.14.6 Astellas Pharma Competitive Strengths & Weaknesses
    7.15 Aguettant
        7.15.1 Aguettant Details
        7.15.2 Aguettant Major Business
        7.15.3 Aguettant Dihydropyridine Vasodilators Product and Services
        7.15.4 Aguettant Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025)
        7.15.5 Aguettant Recent Developments/Updates
        7.15.6 Aguettant Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Dihydropyridine Vasodilators Industry Chain
    8.2 Dihydropyridine Vasodilators Upstream Analysis
    8.3 Dihydropyridine Vasodilators Midstream Analysis
    8.4 Dihydropyridine Vasodilators Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Dihydropyridine Vasodilators Revenue by Region (2020, 2024 and 2031) & (USD Million), (by Headquarter Location)
 Table 2. World Dihydropyridine Vasodilators Revenue by Region (2020-2025) & (USD Million), (by Headquarter Location)
 Table 3. World Dihydropyridine Vasodilators Revenue by Region (2026-2031) & (USD Million), (by Headquarter Location)
 Table 4. World Dihydropyridine Vasodilators Revenue Market Share by Region (2020-2025), (by Headquarter Location)
 Table 5. World Dihydropyridine Vasodilators Revenue Market Share by Region (2026-2031), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Dihydropyridine Vasodilators Consumption Value Growth Rate Forecast by Region (2020 & 2024 & 2031) & (USD Million)
 Table 8. World Dihydropyridine Vasodilators Consumption Value by Region (2020-2025) & (USD Million)
 Table 9. World Dihydropyridine Vasodilators Consumption Value Forecast by Region (2026-2031) & (USD Million)
 Table 10. World Dihydropyridine Vasodilators Revenue by Player (2020-2025) & (USD Million)
 Table 11. Revenue Market Share of Key Dihydropyridine Vasodilators Players in 2024
 Table 12. World Dihydropyridine Vasodilators Industry Rank of Major Player, Based on Revenue in 2024
 Table 13. Global Dihydropyridine Vasodilators Company Evaluation Quadrant
 Table 14. Head Office of Key Dihydropyridine Vasodilators Players
 Table 15. Dihydropyridine Vasodilators Market: Company Product Type Footprint
 Table 16. Dihydropyridine Vasodilators Market: Company Product Application Footprint
 Table 17. Dihydropyridine Vasodilators Mergers & Acquisitions Activity
 Table 18. United States VS China Dihydropyridine Vasodilators Revenue Comparison, (2020 & 2024 & 2031) & (USD Million)
 Table 19. United States VS China Dihydropyridine Vasodilators Consumption Value Comparison, (2020 & 2024 & 2031) & (USD Million)
 Table 20. United States Based Dihydropyridine Vasodilators Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Dihydropyridine Vasodilators Revenue, (2020-2025) & (USD Million)
 Table 22. United States Based Companies Dihydropyridine Vasodilators Revenue Market Share (2020-2025)
 Table 23. China Based Dihydropyridine Vasodilators Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Dihydropyridine Vasodilators Revenue, (2020-2025) & (USD Million)
 Table 25. China Based Companies Dihydropyridine Vasodilators Revenue Market Share (2020-2025)
 Table 26. Rest of World Based Dihydropyridine Vasodilators Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Dihydropyridine Vasodilators Revenue (2020-2025) & (USD Million)
 Table 28. Rest of World Based Companies Dihydropyridine Vasodilators Revenue Market Share (2020-2025)
 Table 29. World Dihydropyridine Vasodilators Market Size by Type, (USD Million), 2020 & 2024 & 2031
 Table 30. World Dihydropyridine Vasodilators Market Size Value by Type (2020-2025) & (USD Million)
 Table 31. World Dihydropyridine Vasodilators Market Size by Type (2026-2031) & (USD Million)
 Table 32. World Dihydropyridine Vasodilators Market Size by Application, (USD Million), 2020 & 2024 & 2031
 Table 33. World Dihydropyridine Vasodilators Market Size by Application (2020-2025) & (USD Million)
 Table 34. World Dihydropyridine Vasodilators Market Size by Application (2026-2031) & (USD Million)
 Table 35. Bayer Basic Information, Manufacturing Base and Competitors
 Table 36. Bayer Major Business
 Table 37. Bayer Dihydropyridine Vasodilators Product and Services
 Table 38. Bayer Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025) & (USD Million)
 Table 39. Bayer Recent Developments/Updates
 Table 40. Bayer Competitive Strengths & Weaknesses
 Table 41. Huanghai Pharma Basic Information, Manufacturing Base and Competitors
 Table 42. Huanghai Pharma Major Business
 Table 43. Huanghai Pharma Dihydropyridine Vasodilators Product and Services
 Table 44. Huanghai Pharma Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025) & (USD Million)
 Table 45. Huanghai Pharma Recent Developments/Updates
 Table 46. Huanghai Pharma Competitive Strengths & Weaknesses
 Table 47. Shyndec Pharma Basic Information, Manufacturing Base and Competitors
 Table 48. Shyndec Pharma Major Business
 Table 49. Shyndec Pharma Dihydropyridine Vasodilators Product and Services
 Table 50. Shyndec Pharma Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025) & (USD Million)
 Table 51. Shyndec Pharma Recent Developments/Updates
 Table 52. Shyndec Pharma Competitive Strengths & Weaknesses
 Table 53. Beijing Hongling Pharma Basic Information, Manufacturing Base and Competitors
 Table 54. Beijing Hongling Pharma Major Business
 Table 55. Beijing Hongling Pharma Dihydropyridine Vasodilators Product and Services
 Table 56. Beijing Hongling Pharma Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025) & (USD Million)
 Table 57. Beijing Hongling Pharma Recent Developments/Updates
 Table 58. Beijing Hongling Pharma Competitive Strengths & Weaknesses
 Table 59. Ingenus Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 60. Ingenus Pharmaceutical Major Business
 Table 61. Ingenus Pharmaceutical Dihydropyridine Vasodilators Product and Services
 Table 62. Ingenus Pharmaceutical Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025) & (USD Million)
 Table 63. Ingenus Pharmaceutical Recent Developments/Updates
 Table 64. Ingenus Pharmaceutical Competitive Strengths & Weaknesses
 Table 65. Sine Pharma Basic Information, Manufacturing Base and Competitors
 Table 66. Sine Pharma Major Business
 Table 67. Sine Pharma Dihydropyridine Vasodilators Product and Services
 Table 68. Sine Pharma Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025) & (USD Million)
 Table 69. Sine Pharma Recent Developments/Updates
 Table 70. Sine Pharma Competitive Strengths & Weaknesses
 Table 71. AstraZeneca Basic Information, Manufacturing Base and Competitors
 Table 72. AstraZeneca Major Business
 Table 73. AstraZeneca Dihydropyridine Vasodilators Product and Services
 Table 74. AstraZeneca Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025) & (USD Million)
 Table 75. AstraZeneca Recent Developments/Updates
 Table 76. AstraZeneca Competitive Strengths & Weaknesses
 Table 77. Lifeon Pharma Basic Information, Manufacturing Base and Competitors
 Table 78. Lifeon Pharma Major Business
 Table 79. Lifeon Pharma Dihydropyridine Vasodilators Product and Services
 Table 80. Lifeon Pharma Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025) & (USD Million)
 Table 81. Lifeon Pharma Recent Developments/Updates
 Table 82. Lifeon Pharma Competitive Strengths & Weaknesses
 Table 83. Teva Basic Information, Manufacturing Base and Competitors
 Table 84. Teva Major Business
 Table 85. Teva Dihydropyridine Vasodilators Product and Services
 Table 86. Teva Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025) & (USD Million)
 Table 87. Teva Recent Developments/Updates
 Table 88. Teva Competitive Strengths & Weaknesses
 Table 89. Nanjing Easeheal Pharma Basic Information, Manufacturing Base and Competitors
 Table 90. Nanjing Easeheal Pharma Major Business
 Table 91. Nanjing Easeheal Pharma Dihydropyridine Vasodilators Product and Services
 Table 92. Nanjing Easeheal Pharma Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025) & (USD Million)
 Table 93. Nanjing Easeheal Pharma Recent Developments/Updates
 Table 94. Nanjing Easeheal Pharma Competitive Strengths & Weaknesses
 Table 95. Novartis Basic Information, Manufacturing Base and Competitors
 Table 96. Novartis Major Business
 Table 97. Novartis Dihydropyridine Vasodilators Product and Services
 Table 98. Novartis Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025) & (USD Million)
 Table 99. Novartis Recent Developments/Updates
 Table 100. Novartis Competitive Strengths & Weaknesses
 Table 101. Baxter International Basic Information, Manufacturing Base and Competitors
 Table 102. Baxter International Major Business
 Table 103. Baxter International Dihydropyridine Vasodilators Product and Services
 Table 104. Baxter International Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025) & (USD Million)
 Table 105. Baxter International Recent Developments/Updates
 Table 106. Baxter International Competitive Strengths & Weaknesses
 Table 107. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 108. Hikma Pharmaceuticals Major Business
 Table 109. Hikma Pharmaceuticals Dihydropyridine Vasodilators Product and Services
 Table 110. Hikma Pharmaceuticals Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025) & (USD Million)
 Table 111. Hikma Pharmaceuticals Recent Developments/Updates
 Table 112. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
 Table 113. Astellas Pharma Basic Information, Manufacturing Base and Competitors
 Table 114. Astellas Pharma Major Business
 Table 115. Astellas Pharma Dihydropyridine Vasodilators Product and Services
 Table 116. Astellas Pharma Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025) & (USD Million)
 Table 117. Astellas Pharma Recent Developments/Updates
 Table 118. Astellas Pharma Competitive Strengths & Weaknesses
 Table 119. Aguettant Basic Information, Manufacturing Base and Competitors
 Table 120. Aguettant Major Business
 Table 121. Aguettant Dihydropyridine Vasodilators Product and Services
 Table 122. Aguettant Dihydropyridine Vasodilators Revenue, Gross Margin and Market Share (2020-2025) & (USD Million)
 Table 123. Aguettant Recent Developments/Updates
 Table 124. Aguettant Competitive Strengths & Weaknesses
 Table 125. Global Key Players of Dihydropyridine Vasodilators Upstream (Raw Materials)
 Table 126. Global Dihydropyridine Vasodilators Typical Customers


List of Figures
 Figure 1. Dihydropyridine Vasodilators Picture
 Figure 2. World Dihydropyridine Vasodilators Total Revenue: 2020 & 2024 & 2031, (USD Million)
 Figure 3. World Dihydropyridine Vasodilators Total Revenue (2020-2031) & (USD Million)
 Figure 4. World Dihydropyridine Vasodilators Revenue by Region (2020, 2024 and 2031) & (USD Million), (by Headquarter Location)
 Figure 5. World Dihydropyridine Vasodilators Revenue Market Share by Region (2020-2031), (by Headquarter Location)
 Figure 6. United States Based Company Dihydropyridine Vasodilators Revenue (2020-2031) & (USD Million)
 Figure 7. China Based Company Dihydropyridine Vasodilators Revenue (2020-2031) & (USD Million)
 Figure 8. Europe Based Company Dihydropyridine Vasodilators Revenue (2020-2031) & (USD Million)
 Figure 9. Japan Based Company Dihydropyridine Vasodilators Revenue (2020-2031) & (USD Million)
 Figure 10. South Korea Based Company Dihydropyridine Vasodilators Revenue (2020-2031) & (USD Million)
 Figure 11. ASEAN Based Company Dihydropyridine Vasodilators Revenue (2020-2031) & (USD Million)
 Figure 12. India Based Company Dihydropyridine Vasodilators Revenue (2020-2031) & (USD Million)
 Figure 13. Dihydropyridine Vasodilators Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Dihydropyridine Vasodilators Consumption Value (2020-2031) & (USD Million)
 Figure 16. World Dihydropyridine Vasodilators Consumption Value Market Share by Region (2020-2031)
 Figure 17. United States Dihydropyridine Vasodilators Consumption Value (2020-2031) & (USD Million)
 Figure 18. China Dihydropyridine Vasodilators Consumption Value (2020-2031) & (USD Million)
 Figure 19. Europe Dihydropyridine Vasodilators Consumption Value (2020-2031) & (USD Million)
 Figure 20. Japan Dihydropyridine Vasodilators Consumption Value (2020-2031) & (USD Million)
 Figure 21. South Korea Dihydropyridine Vasodilators Consumption Value (2020-2031) & (USD Million)
 Figure 22. ASEAN Dihydropyridine Vasodilators Consumption Value (2020-2031) & (USD Million)
 Figure 23. India Dihydropyridine Vasodilators Consumption Value (2020-2031) & (USD Million)
 Figure 24. Producer Shipments of Dihydropyridine Vasodilators by Player Revenue ($MM) and Market Share (%): 2024
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Dihydropyridine Vasodilators Markets in 2024
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Dihydropyridine Vasodilators Markets in 2024
 Figure 27. United States VS China: Dihydropyridine Vasodilators Revenue Market Share Comparison (2020 & 2024 & 2031)
 Figure 28. United States VS China: Dihydropyridine Vasodilators Consumption Value Market Share Comparison (2020 & 2024 & 2031)
 Figure 29. World Dihydropyridine Vasodilators Market Size by Type, (USD Million), 2020 & 2024 & 2031
 Figure 30. World Dihydropyridine Vasodilators Market Size Market Share by Type in 2024
 Figure 31. Nifedipine
 Figure 32. Iradipine
 Figure 33. Felodipine
 Figure 34. Nicardipine
 Figure 35. Other
 Figure 36. World Dihydropyridine Vasodilators Market Size Market Share by Type (2020-2031)
 Figure 37. World Dihydropyridine Vasodilators Market Size by Application, (USD Million), 2020 & 2024 & 2031
 Figure 38. World Dihydropyridine Vasodilators Market Size Market Share by Application in 2024
 Figure 39. Hospital
 Figure 40. Retail Pharmacy
 Figure 41. Other
 Figure 42. World Dihydropyridine Vasodilators Market Size Market Share by Application (2020-2031)
 Figure 43. Dihydropyridine Vasodilators Industrial Chain
 Figure 44. Methodology
 Figure 45. Research Process and Data Source

Companies Mentioned

Bayer
Huanghai Pharma
Shyndec Pharma
Beijing Hongling Pharma
Ingenus Pharmaceutical
Sine Pharma
AstraZeneca
Lifeon Pharma
Teva
Nanjing Easeheal Pharma
Novartis
Baxter International
Hikma Pharmaceuticals
Astellas Pharma
Aguettant